In a massive victory for Democrats, Medicare is poised to negotiate drug prices
WASHINGTON — President Biden is on the verge of his own crowning health care achievement to call, in his words, a BFD.
After two decades, Democrats are finally on track to break the firewall between the pharmaceutical industry and the Medicare program. Soon, the U.S. government will be able to use the full brunt of its leverage to negotiate discounts from drug makers, like the governments in many other developed countries.
